A department of pharmacology that offers doctoral training. The Department of Pharmacology and Therapeutics of McGill University is a research-intensive department with a strong commitment to teaching at the undergraduate, graduate and postgraduate levels. Our full and affiliated members lead over thirty different research programs and are training over eighty graduate students. Our undergraduate program currently offers Majors, Honors and Minors programs in Pharmacology. The Department has interests in both basic and clinical areas of research, although its emphasis is on the basic sciences. The Department is constantly adding to its expertise by attracting new or affiliated members to its growing staff. Of the present 38 full or affiliated staff members, the repertoire of its research specialties includes neuropharmacology, reproductive, endocrine, receptor, cardiovascular, cancer, developmental, clinical, autonomic and biochemical pharmacology, molecular biology, proteomics, genomics and toxicology. Neuropharmacology involves the study and treatment of debilitating diseases of the nervous system, such as Alzheimer''s or Parkinson''s disease, epilepsy, multiple sclerosis, mental depression and drug abuse. Investigations in this field are by definition multidisciplinary in nature. They address the fundamental mechanisms underlying drug action in the nervous system, and the knowledge already gained through the research of several of our staff members should lead to the discovery of novel treatments for these disorders. Other colleagues are studying how certain drugs act to combat arrhythmias (abnormal heart rhythms). Infertility, a serious medical problem affecting 250,000 Canadians, is also under investigation in the Department. In focusing on male infertility, research being undertaken is aimed at improving our understanding of this condition. It also includes the development of strategies to improve methods of contraception with fewer side effects, including a male contraceptive pill. As well, toxic effects of drugs on animal models, particularly in pregnancy and in the developing embryo are being studied. Using molecular biological approaches, we are studying the mechanisms triggering pathological cell changes which cause cancer and many other diseases, to discover ways to control them. The possibility of using genetic elements as a new class of therapeutic agents is also being investigated.
Resource Type: Resource
Version: Latest Version
Mcgill University; Department of Pharmacology and Therapeutics, McGill Dept. of Pharmacology and Therapeutics, McGill Pharmacology and Therapeutics, Mcgill University Faculty of Medicine; Department of Pharmacology and Therapeutics
Additional Resource Types
Department Portal, Graduate Program Resource, Undergraduate Program Resource
Created 2 weeks ago by Christie Wang
Created 5 years ago by Anonymous